SS18 and synovial sarcoma: Together, these results show that introduction of SS18-SSX1 into eMCs can induce sarcomas which recapitulated the phenotypes of human synovial sarcoma, such as typical biphasic morphologies and expression of synovial sarcoma-specific biomarkers.